Format

Send to

Choose Destination
See comment in PubMed Commons below
Dermatology. 2005;210(4):279-85.

Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage.

Author information

  • 1Department of Dermatology, Ghent University Hospital, Ghent, Belgium. katia.ongenae@ugent.be

Abstract

BACKGROUND:

Few studies have paid attention to the effects of treatment interventions on the psychosocial consequences of vitiligo.

OBJECTIVES:

To quantify and analyse the psychosocial benefit of the use of camouflage in vitiligo patients.

PATIENTS AND METHODS:

78 vitiligo patients completed the Dermatology Life Quality Index (DLQI) and an adapted stigmatization questionnaire, and 62 of them completed the DLQI after at least a 1-month use of camouflage.

RESULTS:

The initial mean overall DLQI score (n = 78) is 6.9 (SD 5.6). The mean global stigmatization score is 38%. Disease extent and disease severity are strong predictors of the DLQI (p < 0.0001). Vitiligo on the face/head/neck substantially affects the DLQI, independently of degree of involvement. The mean DLQI score before and after use of camouflage (n = 62) is 7.3 (SD 5.6) and 5.9 (SD 5.2; p = 0.006). Mainly the high-scoring items 'feelings of embarrassment and self consciousness' and 'choice of clothing' improve. Predictors of improvement are higher DLQI scores (p = 0.0005) and higher total severity scores (p = 0.03).

CONCLUSIONS:

Camouflage can be recommended, particularly in patients with higher DLQI scores or self-assessed disease severity. Patients with minor involvement of the face benefit from camouflage.

2005 S. Karger AG, Basel

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for S. Karger AG, Basel, Switzerland
    Loading ...
    Write to the Help Desk